Pliant Therapeutics Inc (NASDAQ: PLRX): Stock Forecast For 2025 Still Looks Weak With A -1110.19% Decline
In today’s recent session, 8.09 million shares of the Pliant Therapeutics Inc (NASDAQ:PLRX) have been traded, and its beta is 1.07. Most recently the company’s